• Guangdong Tashao Tengxiang Technology Co., Ltd. is the only listed hearing aid/hearing amplifier manufacturer in, renowned for providing high-quality and reasonable hearing aids/hearing amplifiers.
•  

We have passed the BSCI, ISO13485, ISO900, C-TP, SQP, CVS HEALTH audits, and all our products come with CE, RoHS, and FDA certificates. We have our own R&D and more than 30 experienced engineers, and we have the capability to handle ODM and OEM projects.

After the company was legally registered, the business scope includes production, processing, sales: electronic products: auditory tuning forks, audiometers, otoacoustic emitters, tympanometers, implantable bone conduction hearing, cochlear sound processors, bone bridge sound processors, bone conduction processors, auditory rehabilitation training instruments, behind-the-ear, in-the-ear, box-type bone conduction hearing aids; portable oxygen breathing devices, portable oxygen generators, medical breathing humidifiers, medical oxygen humidifiers, atomizing tubes, atomizing straws atomizing masks, medical ultrasonic atomizers, compressed atomizers, medical atomizers, atomizers, atomizing components; glass mercury thermometers, thermometers, thermometers, pulse oximeters, blood pressure monitors, glucose meters; electric wheelchairs, manual wheelchairs, medical orthopedics, elbow supports, cr, standing electric heating, medical air mattresses, fetal heart pumps, breast pumps, cupping, desiccants, physiotherapy, pulse generators; import and export goods and technology.

•  
• Business type: Manufacturer, trading company
• Main products: Hearing aids
• Total employees: 201-300
• Established year 2003
• Product certification: CE, ROHS, IPX8, test report, medical CE, FDA
• Trademarks: Jinghao,isound, Noon Plus, Carlitos, Unisound, VitalControl, King Health, Johntone.
• Location: Guangdong, China (Mainland)
• Ownership: Public Company
• Annual Total Revenue: Confidential
• Certification: ISO13485, ISO9001
• Patent: Design Patent Certificate
• Main Market: North America 28.32%; Eastern Europe 27.21%; 14.15%
•  
•  
•  
•